Adamax: A Laboratory Research Reference

Adamax is a synthetic derivative of the nootropic peptide Semax, modified with an adamantane group and N-terminal acetylation. It is described in research-chemical literature as an analogue designed for improved stability and blood–brain penetration, studied in laboratory settings.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, molecular characteristics, mechanism as described in the literature, research areas, and analytical testing of Adamax. It does not provide dosing, therapeutic, or human-use guidance of any kind. Adamax supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is Adamax?

Adamax is derived from Semax, itself a heptapeptide analogue of the adrenocorticotropic hormone fragment ACTH(4–10). Semax consists of the amino-terminal ACTH(4–7) sequence (Met-Glu-His-Phe) with a carboxy-terminal Pro-Gly-Pro tripeptide added to resist enzymatic degradation. Adamax builds on this scaffold by attaching a lipophilic adamantane (adamantyl) group and acetylating the amino terminus, modifications intended to increase lipophilicity and central nervous system penetration.

Unlike Semax, Adamax has no widely indexed peer-reviewed literature under its own name; its described properties rest on the Semax scaffold and on the general behaviour of adamantane modifications. For background on how synthetic research peptides are produced and verified, see the synthetic peptides research guide.

Molecular Characteristics

• Classification: a synthetic, adamantane-modified derivative of the peptide Semax (an ACTH fragment analogue).
• Modifications: N-terminal acetylation and addition of a lipophilic adamantane group.
• Molecular weight: reported in Daltons (Da) on product documentation; the measured value on a Certificate of Analysis should be compared against the theoretical mass.
• Physical form: supplied as a lyophilised (freeze-dried) powder, the standard presentation for research peptides.

How Adamax Works

The Semax scaffold from which Adamax is derived is studied for neurotrophic and cognitive signalling in preclinical models, acting in part through pathways that modulate brain-derived neurotrophic factor (BDNF) expression. The adamantane group in Adamax is understood to increase lipophilicity and membrane penetration, a strategy shared with other adamantane-containing molecules. Direct mechanistic study of Adamax itself is limited in the published literature.

These observations are preliminary and preclinical; they do not constitute a therapeutic use.

Areas of Scientific Research

• Peptide modification: study of adamantane and acetyl modifications on a neuropeptide scaffold.
• Stability and penetration: investigation of lipophilicity and membrane penetration as a function of modification.
• Nootropic-peptide family: comparison with Semax and related ACTH fragment analogues.

These investigations are conducted in vitro or in approved animal research models under institutional oversight. They do not translate to approved human use.

Analytical Testing

• HPLC for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry for identity confirmation, reflecting the adamantane modification.

Guidance on reading the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Storage and Handling

In a laboratory context, lyophilised Adamax is typically stored in a freezer, protected from light and moisture, and handled according to the product-specific documentation. General guidance is covered in the peptide storage and stability reference.

Frequently Asked Questions

• What is Adamax? Adamax is a synthetic, adamantane-bearing derivative of the peptide Semax.
• What is Semax? Semax is a heptapeptide analogue of the ACTH(4–10) fragment.
• Why is the adamantane group added? It increases lipophilicity and is intended to improve membrane penetration.
• How does Adamax differ from Semax? Adamax carries an adamantane group and N-terminal acetylation not present in plain Semax.
• How is Adamax purity tested? By HPLC, with identity confirmed by mass spectrometry.

References

• Adamax has no widely indexed peer-reviewed publications under its own name. The description above is drawn from the established Semax literature and the general pharmacology of adamantane modifications; readers are referred to Semax-related primary sources for the scaffold on which Adamax is based.

Related Research Resources

• Semax: A Laboratory Research Reference — the peptide scaffold from which Adamax is derived.
• Synthetic Peptides: Research Guide — how research peptides are produced and verified.